Nova Patents
MA42844A

Therapeutic combinations comprising anti-folr1 immunoconjugates

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

36 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
201562220028United States of AmericaP
201562242669United States of AmericaP
201562250756United States of AmericaP

Members36

Family members, oldest first
DocumentOfficeKind
CA2994888A1CanadaA1
WO2017049149A1World Intellectual Property Organization (WIPO)A1
US2017095571A1United States of AmericaA1
AU2016323968A1AustraliaA1
IL257531AIsraelA
IL257531D0IsraelD0
KR20180053319ARepublic of KoreaA
EP3349796A1European Patent Office (EPO)A1
MA42844AThis recordMoroccoA
JP2018527383AJapanA
CN108601828AChinaA
US10172875B2United States of AmericaB2
EP3349796A4European Patent Office (EPO)A4
US2019167704A1United States of AmericaA1
HK1255141AHong Kong, ChinaA
HK1255141A1Hong Kong, ChinaA1
RU2018111205ARussian FederationA
RU2018111205A3Russian FederationA3
US2020397806A1United States of AmericaA1
JP6880006B2JapanB2
US11033564B2United States of AmericaB2
RU2749865C2Russian FederationC2
JP2021107452AJapanA
US2022168326A1United States of AmericaA1
IL257531BIsraelB
IL298438AIsraelA
IL257531B2IsraelB2
CN108601828BChinaB
AU2016323968B2AustraliaB2
CN116440279AChinaA
JP2023101813AJapanA
AU2023233173A1AustraliaA1
KR102700777B1Republic of KoreaB1
JP7703593B2JapanB2
JP2025129187AJapanA
IL323626AIsraelA